Urinary Infection in Pregnant Women with Urinary Infection
NCT ID: NCT06752161
Last Updated: 2025-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
224 participants
OBSERVATIONAL
2024-02-01
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urine Alkalinization for UTI in Women: RCT
NCT07202832
Intravesical Gentamicin to Prevent Recurrent UTI
NCT06332781
Microbiological Characterization and Antibiotic Resistance Profiling of Providencia Spp,: An Emerging Pathogen Isolated From Urinary Tract Infections
NCT07204769
Urinary Tract Infection in Patients With Chronic Kidney Disease
NCT05674942
Evaluating UTI Diagnosis in Nursing Homes
NCT04815369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women with threatened preterm labour
Patients with UTI and preterm labour
Urine analysis
Urine analysis and culture for Screening and diagnostic tools for UTI in pregnant women
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urine analysis
Urine analysis and culture for Screening and diagnostic tools for UTI in pregnant women
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Gamal M.fekry
Lecturer of obstetric and gynecology, specialist of Uro gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohammed Seif al nasr, MBBCH
Role: PRINCIPAL_INVESTIGATOR
Women's Health Hospital Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women's Health Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UTIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.